Nuvation Bio (NUVB) Cash & Equivalents (2023 - 2025)
Historic Cash & Equivalents for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $98.9 million.
- Nuvation Bio's Cash & Equivalents rose 22926.16% to $98.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.9 million, marking a year-over-year increase of 22926.16%. This contributed to the annual value of $35.7 million for FY2024, which is 1623.95% down from last year.
- Latest data reveals that Nuvation Bio reported Cash & Equivalents of $98.9 million as of Q3 2025, which was up 22926.16% from $248.0 million recorded in Q2 2025.
- Nuvation Bio's Cash & Equivalents' 5-year high stood at $248.0 million during Q2 2025, with a 5-year trough of $24.4 million in Q3 2023.
- For the 3-year period, Nuvation Bio's Cash & Equivalents averaged around $61.5 million, with its median value being $35.7 million (2024).
- In the last 5 years, Nuvation Bio's Cash & Equivalents tumbled by 3151.9% in 2024 and then skyrocketed by 62326.09% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Cash & Equivalents stood at $42.6 million in 2023, then dropped by 16.24% to $35.7 million in 2024, then skyrocketed by 176.84% to $98.9 million in 2025.
- Its Cash & Equivalents stands at $98.9 million for Q3 2025, versus $248.0 million for Q2 2025 and $48.0 million for Q1 2025.